Book Building - SME
₹ 27.56 cr
₹ 123
1000
₹ 1,23,000.00
BSE - SME
09-Jul-2025
11-Jul-2025
16-Jul-2025
The Shares of Asston Pharmaceuticals Ltd have now been listed.
Initial public issue of up to 22,41,000 equity shares of face value of Rs.10/- each (the Equity Shares) of Asston Pharmaceuticals Limited (the Company or APL or the Issuer) at an issue price of Rs. 123 per equity share for cash, aggregating up to Rs. 27.56 crores (Public Isue) out of which upto 1,13,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating Rs. 1.39 crores will be reserved for subscription by the market maker to the issue (the Market Maker Reservation Portion). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 123 per equity share for cash, aggregating upto Rs. 26.17 crores is herein after referred to as the Net Issue. The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company.
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit. Funding the incremental working capital requirements of our company. Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company.. General corporate purposes.
Asston Pharmaceuticals Ltd, 451 Krishna Apra Bus, Netaji Subhash Place, Pitampura, New Delhi-110034
Phone - 011-45121795
Fax - 01145121795
Email - info@asstonpharmaceuticals.com
Website - www.asstonpharmaceuticals.com